心房颤动的当前问题
Current issues in atrial fibrillation.
作者信息
Khaykin Yaariv, Shamiss Yana
机构信息
Heart Rhythm Program, Southlake Regional Health Centre, 105-712 Davis Drive, Newmarket, ON, Canada L3Y 8C3.
出版信息
ISRN Cardiol. 2012;2012:376071. doi: 10.5402/2012/376071. Epub 2012 Jun 21.
Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It places an enormous burden on the patients, caregivers, and the society at large. While the main themes in the care of an AF patient have not changed over the years and continue to focus on stroke prevention, control of the ventricular, rate and rhythm maintenance, there have been a number of new developments in each of these realms. This paper will discuss the "hot" topics in AF in 2012 including new and upcoming medical and invasive management strategies for this condition.
摘要
心房颤动（AF）是最常见的持续性心律失常。它给患者、护理人员以及整个社会带来了巨大负担。尽管多年来房颤患者护理的主要主题并未改变，仍然集中在预防中风、控制心室率以及维持心律方面，但在这些领域中的每一个都有了一些新进展。本文将讨论2012年房颤领域的“热门”话题，包括针对这种病症的新的和即将出现的药物及侵入性治疗策略。
相似文献
1
Current issues in atrial fibrillation.心房颤动的当前问题
ISRN Cardiol. 2012;2012:376071. doi: 10.5402/2012/376071. Epub 2012 Jun 21.
3
Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.心房颤动的管理：二十年的进展——欧洲心律失常学会的科学声明。
J Interv Card Electrophysiol. 2022 Oct;65(1):287-326. doi: 10.1007/s10840-022-01195-z. Epub 2022 Apr 13.
4
Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.改善心房颤动患者的结局：预防卒中的心房颤动早期治疗试验的原理和设计。
Am Heart J. 2013 Sep;166(3):442-8. doi: 10.1016/j.ahj.2013.05.015. Epub 2013 Jul 30.
5
Treatment of atrial fibrillation: a comprehensive review and practice guide.心房颤动的治疗：全面综述与实践指南
Cardiovasc J Afr. 2020;31(3):153-158. doi: 10.5830/CVJA-2019-064. Epub 2020 Mar 18.
6
Atrial fibrillation: stroke prevention in focus.心房颤动：聚焦卒中预防
Aust Crit Care. 2014 May;27(2):92-8. doi: 10.1016/j.aucc.2013.08.002. Epub 2013 Sep 18.
7
New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.心房颤动管理的新方法：对一个快速发展领域的批判性综述。
Drugs. 2002;62(16):2377-97. doi: 10.2165/00003495-200262160-00005.
8
The role of pacing in rhythm control and management of atrial fibrillation.起搏在心房颤动的节律控制和管理中的作用。
J Interv Card Electrophysiol. 2007 Mar;18(2):159-86. doi: 10.1007/s10840-007-9087-z. Epub 2007 May 2.
9
[Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].[糖尿病对持续性心房颤动患者窦性心律恢复及维持的影响]
Srp Arh Celok Lek. 2002 May-Jun;130(5-6):189-92. doi: 10.2298/sarh0206189p.
10
Lifestyle management to prevent and treat atrial fibrillation.预防和治疗心房颤动的生活方式管理
Expert Rev Cardiovasc Ther. 2016 Jul;14(7):799-809. doi: 10.1080/14779072.2016.1179581. Epub 2016 May 3.
本文引用的文献
1
Subclinical atrial fibrillation and the risk of stroke.无症状性心房颤动与卒中风险。
N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575.
2
Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.导管消融治疗心房颤动后的程序并发症、再住院和重复手术。
J Am Coll Cardiol. 2012 Jan 10;59(2):143-9. doi: 10.1016/j.jacc.2011.08.068.
3
Dronedarone in high-risk permanent atrial fibrillation.盐酸决奈达隆治疗高危持续性心房颤动
N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14.
4
Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.采用消融策略维持心房颤动患者的窦性心律与较低的中风和死亡风险相关。
Heart. 2012 Jan;98(1):48-53. doi: 10.1136/heartjnl-2011-300720. Epub 2011 Sep 19.
5
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.在健康受试者中，用凝血酶原复合物浓缩物逆转利伐沙班和达比加群：一项随机、安慰剂对照、交叉研究。
Circulation. 2011 Oct 4;124(14):1573-9. doi: 10.1161/CIRCULATIONAHA.111.029017. Epub 2011 Sep 6.
6
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
7
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.利伐沙班与华法林用于非瓣膜性心房颤动。
N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.
8
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.一种新的预测华法林相关出血风险的方案：ATRIA（心房颤动抗凝和危险因素）研究。
J Am Coll Cardiol. 2011 Jul 19;58(4):395-401. doi: 10.1016/j.jacc.2011.03.031.
9
Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging.消融后无症状性脑损伤：磁共振成像的长期随访。
Heart Rhythm. 2011 Nov;8(11):1705-11. doi: 10.1016/j.hrthm.2011.06.030. Epub 2011 Jul 2.
10
Clinical predictors of arrhythmia recurrences following pulmonary vein antrum isolation for atrial fibrillation: predicting arrhythmia recurrence post-PVAI.房颤行肺静脉电隔离术后心律失常复发的临床预测因素：预测 PVAI 后心律失常复发。
J Cardiovasc Electrophysiol. 2011 Nov;22(11):1206-14. doi: 10.1111/j.1540-8167.2011.02108.x. Epub 2011 Jun 10.
Zotero 插件